Jamie S Lin, MD
Department of Emergency Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Instructor, Department of Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2010 | University of Nebraska Medical Center College of Medicine, Omaha, NE, USA, MD, Medicine |
| 2005 | University of Pennsylyvania, Philadelphia, PA, USA, BA, Biological Basis of Behavior |
Postgraduate Training
| 2017-2019 | Clinical Fellowship, Onconephrology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2015-2017 | Research Fellowship, Nephrology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA |
| 2013-2015 | Clinical Fellowship, Nephrology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA |
| 2010-2013 | Clinical Internship, Internal Medicine, Baylor College of Medicine, Houston, TX |
Board Certifications
| 2015 | American Board of Internal Medicine, Nephrology |
| 2012 | American Board of Internal Medicine |
Experience & Service
Other Appointments/Responsibilities
Attending Physician, Penn Presbyterian Hospital, Philadelphia, PA, 2015 - 2017
Honors & Awards
| 2017 | Sharon Anderson Research Fellow |
| 2016 | Karen L. Campbell American Society of Nephrology Travel Award, American Society of Nephroogy |
| 2016 | First place, National Young Investigator’s Forum, National Kidney Foundation |
| 2016 | Third place, Johns Hopkins University Mid-Atlantic Regional Young Investigator Forum, John Hopkins University |
| 2014 | Origins of Renal Physiology Mount Desert Island Biologic Laboratory Scholarship, Mount Desert Island Biologic Laboratory |
| 2011 | American Society of Nephrology Kidney STARS Travel Award, American Society of Nephrology |
Selected Publications
Peer-Reviewed Articles
- Galvan DL, Long J, Green N, Chang BH, Lin JS, Schumacker P, Truong LD, Overbeek P, Danesh FR. Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice. J Clin Invest 130(7):2807-2823, 2019. e-Pub 2019. PMID: 31063459.
- Mamlouk O, Selamet U, Machado S, Abdelrahim M, Glass WF, Tchakarov A, Gaber L, Lahoti A, Workeneh B, Chen S, Lin J, Abdel-Wahab N, Tayar J, Lu H, Suarez-Almazor M, Tannir N, Yee C, Diab A, Abudayyeh A. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. J Immunother Cancer 7(1):2, 2019. e-Pub 2019. PMID: 30612580.
- Lin JS, Jeon JS, Fan Q, Wong HN, Palmer MB, Holzman LB. ARF6 mediates nephrin tyrosine phosphorylation-induced podocyte cellular dynamics. PLoS One 12(9):e0184575, 2017. e-Pub 2017. PMID: 28880939.
- Lin JS, Susztak K. Podocytes: the Weakest Link in Diabetic Kidney Disease?. Curr Diab Rep 16(5):45, 2016. PMID: 27053072.
Grant & Contract Support
| Title: | THE ROLE OF ARF6 IN THE PROGRESSION OF DIABETIC KIDNEY DISEASE |
| Funding Source: | NIH/NIDDK |
| Role: | Principal Investigator |